More evidence that cellular 'death by iron' could be promising avenue of cancer treatment
Genetic mutations that give cancers a metabolic boost may also leave them vulnerable to drugs that promote a particular form of cell death, researchers have found.
Source: ScienceDaily
NIO (NYSE: NIO) Partners with NVIDIA (Nasdaq: NVDA) to Develop a New Generation of Automated Driving Electric Vehicles




